Home›Stock Screener›Symbiox Investment & Trading

Symbiox Investment & Trading Share Price Today | Stock Price & Symbiox Investment & Trading Share Screener

SYMBIOX Other Financial Services
Live Share Price BSE
₹1.58
▼ -0.08 (-4.82%)
2026-10-16 00:00:00

As of October 16, 2026, the live Symbiox Investment & Trading share price (BSE: SYMBIOX) is ₹1.58, down 4.82% from the previous close, with shares trading between ₹1.52 and ₹1.65 in today's trading session, and a 52-week range of ₹1.46–₹3.59. Check SYMBIOX yearly price range for the annual price range and momentum. Use the Symbiox Investment & Trading stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Symbiox Investment & Trading opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Symbiox Investment & Trading Market Cap ₹5.10 Cr.
SYMBIOX P/E Ratio (TTM) 32.40
Symbiox Investment & Trading P/B Ratio 0.16
EPS (TTM) ₹0.05
Dividend Yield -
Debt to Equity -
SYMBIOX 52 Week High ₹3.59
Symbiox Investment & Trading 52 Week Low ₹1.46
Operating Margin -
Profit Margin -
SYMBIOX Revenue (TTM) ₹1.00
EBITDA -
Net Income -
Total Assets ₹32.00
Total Equity ₹32.00

Symbiox Investment & Trading Share Price Chart

Track the current stock price of Symbiox Investment & Trading with an interactive chart. Analyse SYMBIOX share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Symbiox Investment & Trading stock quote in one place.

The quote of ₹1.58 sits between the 52-week low of ₹1.46 and the 52-week high of ₹3.59, and the latest session moved -4.82% from the previous close.

Symbiox Investment & Trading Company Profile - Fundamental Screener

Screen Symbiox Investment & Trading company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SYMBIOX shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Financial Services sector and the Other Financial Services industry, and it trades under ISIN INE653R01012.

Company Details

Classification

Sector Financial Services
Industry Other Financial Services
Sub-Sector Other Financial Services
Segment E

Identifiers and Leadership

ISIN INE653R01012

Symbiox Investment & Trading Balance Sheet Screener

Screen SYMBIOX balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹32, down from ₹32 in 2025.

Latest statistics put total assets at ₹32 and shareholder funds at ₹32.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 32 32 32 33 32 33 32 34 33 32
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 32 32 32 31 31 31 31 31 31 31
Share Capital 31 31 31 31 31 31 31 31 31 31
Reserves & Surplus 1 0 0 0 0 0 0 0 0 -1

Symbiox Investment & Trading Income Statement Screener - Profit & Revenue Analysis

Screen Symbiox Investment & Trading income statement and profit fundamentals. Analyze SYMBIOX quarterly results. Symbiox Investment & Trading reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2015-Mar, revenue was ₹1 and net profit was ₹0, equal to earnings per unit of ₹0.01.

Item 2015-Mar

Revenue and Expenses

Revenue 1
Expenses 1

Operating Costs and Margins

EBITDA 0
Operating Profit % 0.00%
Depreciation 0
Interest 0

Profit and Earnings

Profit Before Tax 0
Tax 0
Net Profit 0
EPS 0.01

Symbiox Investment & Trading Cash Flow Screener - Liquidity Fundamentals

Screen SYMBIOX cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹3.

Over the same period, investing activities used ₹3 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 3 4 -3 -5 0 1 0 1 1 2
Investing Activities -3 -3 3 5 0 -1 0 -2 0 -1

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 1 0 0 0 0 0 0 0 0

Symbiox Investment & Trading Shareholding Pattern Screener

See Symbiox Investment & Trading shareholding pattern with promoter, FII, and DII holdings. Check Symbiox Investment & Trading promoter holding and ownership changes for SYMBIOX on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 3.33%, foreign institutions 0.00%, domestic institutions 0.00% and the public 82.31%, spread across 23,623 shareholders.

The shareholder count was 23,623 in 2026-Jun, compared with 23,861 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 3.33% 3.33% 3.33% 3.33% 3.33% 3.33% 3.33% 3.33%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 82.31% 82.25% 81.60% 79.40% 78.40% 82.07% 90.93% 90.94%
Other Holding 14.37% 14.42% 15.07% 17.28% 18.28% 14.61% 5.74% 5.73%
Shareholder Count 23,623 23,861 24,027 24,041 24,304 24,586 25,267 24,443

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Symbiox Investment & Trading. Symbiox Investment & Trading dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Symbiox Investment & Trading.

Symbiox Investment & Trading Stock Index Membership - Nifty & Sensex

See which indices include Symbiox Investment & Trading stock. Check SYMBIOX index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Symbiox Investment & Trading is not part of any tracked indices.
Only major market indices are tracked in our system.

Symbiox Investment & Trading Market Events Screener - Corporate Actions

Get Symbiox Investment & Trading corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Symbiox Investment & Trading stock events that may affect SYMBIOX share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 28, 2026, with a record date of September 28, 2026.

It is followed by Quarterly Result Announcement dated August 12, 2026 and Quarterly Result Announcement dated May 23, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-28 2026-09-28 Annual General Meeting NA 0.00%
2026-08-12 2026-08-12 Quarterly Result Announcement NA 2.94%
2026-05-23 2026-05-23 Quarterly Result Announcement NA -8.51%
2026-02-07 2026-02-07 Quarterly Result Announcement NA 9.73%
2025-11-12 2025-11-12 Quarterly Result Announcement NA 0.00%
2025-09-24 2025-09-24 Annual General Meeting NA -4.12%
2025-08-06 2025-08-06 Quarterly Result Announcement NA -6.09%
2025-05-27 2025-05-27 Quarterly Result Announcement NA -0.97%
2025-02-11 2025-02-11 Quarterly Result Announcement NA -5.23%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 11.18%
2024-09-27 2024-09-27 Annual General Meeting NA 14.92%

Symbiox Investment & Trading Competitors Screener - Peer Stocks Comparison

Screen SYMBIOX competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Financial Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
OnEMI Technology Solutions 6,577 20.99 2,209 63.31% 282 62.41
Algoquant Fintech 1,869 41.61 236 0.34% 33 48.32
Spice Lounge Food Works 1,834 125.86 162 52.16% 10 45.25
Gyftr 1,296 59.68 380 2540.69% 22 52.78
Prime Securities 1,040 222.54 138 54.36% 14 67.34
Wealth First Portfolio Managers 938 28.56 71 18.30% 38 55.00
RNFI Services 844 26.82 974 5.47% 32 61.54
Investment Trust of India 475 12.50 302 -17.34% 35 37.81
Regency Fincorp 462 35.30 40 84.79% 13 66.72
Akiko Global Services 433 19.37 173 126.44% 17 45.59

Symbiox Investment & Trading Company Announcements - News & Reports Screener

Screen SYMBIOX latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated October 10, 2026 and September 29, 2026.

Date Update Actions
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-10 Clarification sought from Symbiox Investment & Trading Company Ltd -
2026-09-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-28 Closure of Trading Window -
2026-09-28 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-04 Reg. 34 (1) Annual Report. -
2026-09-04 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-09-04 Intimation Of Book Closure & Record Dates For The Purpose Of 47Th Annual General Meeting Of The Company Under Regulation 42 Of SEBI (LODR) Regulations 2015 -
2026-09-04 Notice Of 47Th Annual General Meeting Of The Company -
2026-08-26 Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th August 2026 -
2026-08-22 Board Meeting Intimation for Approval And Consideration Of The Director Report And Other Reports And Annexures And Decide On Other Important Matters Related To AGM. -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-12 Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026 For The Quarter Ended On 30Th June 2026. -
2026-08-06 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12Th August 2026 For The Quarter Ended On 30Th June 2026 -
2026-08-04 Non - Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations 2015. -
2026-07-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-25 Closure of Trading Window -
2026-05-30 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-29 Results-Financial For The Year 31.03.2026 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1.58, within a 52-week range of ₹1.46 to ₹3.59. The P/E ratio is 32.40 and the P/B ratio is 0.16, with earnings per unit of ₹0.05. Market capitalisation stands at ₹5.10 Cr. The company operates in the Financial Services sector, in the Other Financial Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 17, 2026. This page covers 10 balance sheet periods, 1 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.